Bill > SB3141

This bill updates Hawaii's Uniform Controlled Substances Act to align with federal changes, specifically by amending Section 329-14 of the Hawaii Revised Statutes. The primary changes involve expanding the list of controlled opiates, which are potent pain-relieving drugs, by adding numerous synthetic opioids like various fentanyl analogues and other related substances, ensuring that these substances are classified and regulated similarly to their federal counterparts. Additionally, the bill revises the list of controlled depressants, which are substances that slow down brain activity, by removing mecloqualone and methaqualone from a general category and reintroducing them as specifically listed controlled substances, while also adding new benzodiazepines like clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam to this schedule. These updates are intended to maintain consistency with the Federal Controlled Substances Act and will take effect on July 1, 2026.

Health and Social Services

https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=SB&billnumber=3141&year=2026